Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib Plus CHOP Every 2 Weeks in Advanced DLBCL
NCT00379574Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Sep 2006
- Primary completion
- Jan 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in diffuse large B-cell lymphoma (DLBCL), sponsored by Asan Medical Center. Started Sep 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00379574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379574.